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The interaction of the mouse hepatitis virus (MHV) nucleocapsid protein (N) and viral RNA was examined.
Monoclonal antibody specific for N protein coimmunoprecipitated MHV genomic RNA as well as all six MHV
subgenomic mRNAs found in MHV-infected cells. In contrast, monoclonal antibodies to the MHV E2 or El
envelope glycoproteins, an anti-I-A monoclonal antibody, and serum samples from lupus patients did not
immunoprecipitate the MHV mRNAs. Moreover, the anti-N monoclonal antibody did not coimmunoprecipitate
vesicular stomatitis virus RNA or host cell RNA under conditions which immunoprecipitated all MHV RNAs.
These data suggest a specific interaction between the N protein and the virus-specific mRNAs. Both the
membrane-bound and cytosolic small MHV leader-specific RNAs of greater than 65 nucleotides long were
immunoprecipitated only by anti-N monoclonal antibody. These data suggest that an N binding site is present
within the leader RNA sequences at a site at least 65 nucleotides from the 5' end of genomic RNA and all six
subgenomic mRNAs. The larger leader-containing RNAs originating from mRNA 1 and mRNA 6, as well as
the MHV negative-stranded RNA, were also immunoprecipitated by the anti-N monoclonal antibody. These
data indicate that the MHV N protein is associated with MHV-specific RNAs and RNA intermediates and may
play an important functional role during MHV transcription and replication.
Mouse hepatitis virus (MHV) is a member of the corona-
virus group of animal viruses. MHV is an enveloped virus
containing a helical nucleocapsid structure composed of a
plus-sensed RNA molecule (5.5 x 106 daltons) and a nucleo-
capsid protein (N) of 60,000 daltons (37). The envelope
contains a 180,000-dalton N-linked glycoprotein (designated
E2) which functions in cell attachment and fusion and an
0-linked matrix glycoprotein of 23,000 daltons (designated
E1) (38).
During infection, virion RNA is initially transcribed by an
early polymerase activity into a genome-sized negative-
stranded RNA (9). In turn, the negative-stranded RNA is
transcribed by a late polymerase activity into a full-length
genomic RNA that is both bound to polysomes (9) and
detected in EDTA-resistant nucleocapsid structures (34).
Viral transcription is associated mainly with membrane
fractions (9, 10). Six species of subgenomic mRNAs are
synthesized during infection. They are arranged in the form
of a nested set with common sequences derived from the 3'
end of the genomic RNA that extend in the 5' direction for
various distances (21, 34, 38). Therefore, each mRNA con-
tains its own unique sequences plus all the sequences
contained within the next smaller mRNA species. In addi-
tion, all viral mRNAs contain an identical leader sequence of
approximately 72 nucleotides at their 5' end (21, 22). Anal-
ysis of MHV-infected cells has revealed the presence of
small leader RNAs 65 to 84 nucleotides long which could
serve a primer function by binding to specific sequences
conserved at the intergenic regions in the negative-strand
template. These leader sequences are derived from the 5'
end of the genomic RNA and are probably joined to the
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individual mRNAs by a unique leader-primed transcription
mechanism (4-6, 21, 25, 32).
The amino acid sequence of N, deduced from the nucleic
acid sequence, reveals that this protein is 455 amino acids
long and highly basic (1, 33). Immediately after synthesis,
the N protein is phosphorylated exclusively on serine resi-
dues. Phosphorylated N is associated with cellular mem-
branes via a strong noncovalent interaction, presumably
through association with the El protein (36, 39). A 140,000-
dalton trimer of N has been described in nonreduced prep-
arations of purified virions by using an RNA protein-overlay
blot assay, suggesting that N protein may exist as a disulfide-
linked multimer in the mature virion (29). The N protein is
also the only RNA-binding protein in virions and is a major
RNA-binding protein found in infected cells (29).
The N protein has a variety of functions in addition to
serving as a structural component of the helical nucleocapsid
(38). It also plays important roles in viral pathogenesis and
replication, since anti-N monoclonal antibodies protect mice
from lethal infection (27) and inhibit viral transcription in
vitro (12); however, the function ofN in viral transcription is
unclear. In this report, we have examined the association of
the N protein with MHV RNA by using an anti-N monoclo-
nal antibody to immunoprecipitate the N-RNA complexes.
In the accompanying article, we have examined the speci-
ficity of N-RNA interactions by a second technique using a
direct RNA-protein binding assay (8, 15, 29, 35). Together,
these data suggest that N protein-MHV RNA interaction is
mediated by binding signals contained within MHV leader
RNA sequences and suggest that this interaction is impor-
tant in viral transcription.
MATERIALS AND METHODS
Virus and cells. The A59 strain ofMHV was used through-
out the course of this study. Virus was propagated in DBT
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cells, a murine astrocytoma cell line, or in L2 cells as
previously described (4, 22, 23). Cells were grown in 150- or
100-mm-diameter petri plates and infected at a multiplicity of
infection of 1 to 5. For experiments using 32Pi to radiolabel
MHV-specific mRNAs, infected cells were treated with 2 ,ug
of actinomycin D per ml at 2.5 h post-infection (p.i.) and
labeled with 500 pLCi of 32p; (ICN Pharmaceuticals Inc.,
Irvine, Calif.) at 4.5 h p.i. Samples were harvested as
described below at 7.5 to 8.5 h p.i. [3H]uridine (ICN) was
added to actinomycin D-treated cells at 15 ,uCi/ml at 4.5 h
p.i. For coinfection studies, the Indiana strain of vesicular
stomatitis virus (VSV) was used at a multiplicity of infection
of 5. Plates were infected with A59 as described above,
incubated for 30 min at 37°C, and subsequently coinfected
with VSV for 1 h at 37°C. Radiolabeled purified virions were
prepared as previously described (23).
Cell lysates. At 7.5 to 8.5 h p.i. the plates were chilled in an
ice-water bath, the medium was removed, and the plates
were washed twice with ice-cold phosphate-buffered saline.
Cells were lysed by the addition of 3 ml of 10 mM Tris buffer
(pH 7.4) containing 150 mM NaCl per plate, 0.5% Nonidet
P-40, and 200 ,ug of phenylmethylsulfonyl fluoride per ml.
After 10 to 15 min the cells were removed with a rubber
policeman and the nuclei and large cell debris were pelleted
by centrifugation at 1,500 x g for 5 min at 4°C. The
supernatant was then adjusted to 10 mM EDTA and 200 mM
ammonium acetate. After an additional centrifugation at
15,000 x g for 10 min, the supernatant was adjusted to 0.2%
sodium dodecyl sulfate (SDS) before immunoprecipitation.
Preparation of P100 or S100 subcellular extracts. Prepara-
tions of subcellular fractions were as previously described
(6). Briefly, cells were swollen in 0.5x reticulocyte standard
buffer (1x reticulocyte standard buffer is 10 mM Tris [pH
7.4], 10 mM NaCl, 1.5 mM MgCl2) for 30 min at 4°C. The
cells were disrupted by Dounce homogenization and centri-
fuged at 1,000 x g for 5 min. The nuclear pellet was
discarded, and the membrane fractions (P100) were sepa-
rated from the cytosol fraction (S100) by centrifugation at
100,000 x g for 90 min. Under these conditions over 90% of
the (Na+K-)-ATPase and 5'-nucleotidase were present in
the P100 fraction (6). Membrane fractions were suspended in
0.5 x reticulocyte standard buffer before immunoprecipita-
tion. RNA in the immunoprecipitates was extracted and
separated on 8 to 12% polyacrylamide gels before electro-
transfer to Zeta-Probe paper (5).
Immunoprecipitation. Immunoprecipitations were carried
out as previously described (14, 16, 36). In these experi-
ments, anti-A59 monoclonal antibodies A.1.10, specific for
N; A.3.10, specific for the E2 envelope glycoprotein; A.1.8,
specific for the El glycoprotein; and 7.16.17, specific for
I-AP, were used (14, 16, 18). Briefly, antibodies were incu-
bated with the cell lysates for 30 min on ice, and then
Formalin-fixed Staphylococcus aureus Cowan 1 was added.
This mixture was incubated 45 min on ice and then washed
twice in 10 mM Tris (pH 7.4) containing 150 mM NaCl, 0.5%
Nonidet P-40, 0.2% SDS, and 200 ,ug of phenylmethylsulfo-
nyl fluoride per ml. The final pellets were suspended in 10
mM Tris (pH 7.4) containing 60 mM NaCl, 1 mM EDTA, and
1.0% SDS. The RNA was extracted with phenol and chlo-
roform as previously described (4, 22) and precipitated
overnight with ethanol at -20°C. RNA was treated with
glyoxal and analyzed by electrophoresis on 1% agarose gels
as previously described (4, 22). Radiolabeled nucleic acids
were visualized by either fluorography or autoradiography
(4, 22).
Immunoprecipitation of the MHV leader RNAs. Cultures of
infected and uninfected cells were lysed and incubated with
a variety of antisera as described above. In addition, antise-
rum samples from systemic lupus erythematosis patients
specific for the La, Rho, Sm, and ribonucleoprotein (RNP)
complexes (kindly provided by Jack Keene, Duke Univer-
sity, Durham, N.C.) were used. After immunoprecipitation
as described by Kurilla and Keene (20), the RNA was
extracted, precipitated, and separated on 8 or 12% poly-
acrylamide gels containing urea (4). The RNA was electro-
transferred to Zeta-Probe paper, prehybridized, and probed
with a nick-translated leader cDNA probe (E1-L) or internal
El sequences (El-500). The El-L cDNA probe encodes
nucleotides 1 to 84 of mRNA 6, including the 72-nucleotide
leader sequence, while E1-500 encodes the internal nucleo-
tides 90 to 609 of mRNA 6 (4). The blots were washed and
exposed to XAR-5 film in the presence of an intensifying
screen at -70°C (4).
Northern (RNA) blots. For Northern analysis, RNA sam-
ples were electrophoresed on 0.8% formaldehyde-agarose
gels and blotted by capillary diffusion to nitrocellulose (40).
Bound RNA was hybridized to a 32P-labeled 1,360-base-pair
fragment of a human gamma actin gene probe, which cross-
hybridizes to mouse actin sequences (11). The hybridization
probe was prepared to a specific activity of 109 cpm/,ug by
the method of Feinberg and Vogelstein (13).
In vitro transcription of MHV strand-specific probes.
Recombinant plasmid pT7-2 11, containing sequences de-
rived from MHV gene F (nucleotides 1 to 760), and plasmid
pT7F82P (nucleotides 5 to 1149) (4, 32), containing se-
quences derived from MHV gene A, are oriented in the
plus-sense configuration so that T7 polymerase-derived tran-
scripts are identical to mRNA and capable of annealing with
MHV negative-stranded but not plus-stranded RNA. Tran-
scription was carried out in a 100-,ul reaction containing 2 ,ug
of linearized plasmid DNA; 40 mM Tris hydrochloride (pH
7.5); 6 mM MgCI2; 2 mM spermidine; 10 mM NaCl; 10 mM
dithiothreitol; 1 mM each ATP, CTP, and GTP; 0.01 mM
UTP; 100 pRCi of [a-32P]UTP; 10 U of T7 RNA polymerase;
and 40 U of RNasin. Reactions were incubated at 37°C for 1
h, and the radiolabeled products were separated from free
nucleotides by chromatography through P-60 columns. Ra-
diolabeled RNAs were mixed with hybridization buffer and
incubated with the filter at 65°C for 24 to 36 h (5, 6).
Detection of MHV negative-stranded RNA. Intracellular
RNA from MHV-infected cells was immunoprecipitated as
described above, denatured by dimethyl sulfoxide-glyoxal or
heat, and applied to nitrocellulose paper by using a dot blot
unit (Bio-Rad Laboratories, Richmond, Calif.). The paper
was baked at 80°C for 2 h, prewashed and prehybridized as
previously described (4, 6), and then probed with plus-
stranded RNA probes (2 x 107 cpm/ml) capable of annealing
with MHV negative-stranded but not plus-stranded RNA or
purified genomic RNA. The filters were hybridized at 65°C
for 24 to 36 h in a solution containing 50% formamide, 10 mM
sodium phosphate (pH 7.0), 1Ox Denhardt solution, 1.83
mM EDTA, 6x SSC (lx SSC is 0.15 M NaCl plus 0.015 M
sodium citrate), 83 jig of tRNA per ml, and 125 ,ug of salmon
sperm DNA per ml. After hybridization, the filters were
washed with several changes of 2x SSC containing 0.01%
SDS and with 0.2 x SSC containing 0.01% SDS at 65 to 70°C.
Finally, blots were treated with 0.5 ,ug of RNase A per ml at
room temperature in 2x SSC for 5 to 15 min. Filters were
exposed to XAR-5 film in the presence of an intensifying
screen at -70°C.
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FIG. 2. Immunoprecipitation of RNA from MHV-infected cells.
Lanes: A and F, controls showing the virus-specific RNA extracted
from infected cells; D, all seven virus-specified RNAs immunopre-
cipitated by the anti-N monoclonal antibody; B, C, and E, immu-
noprecipitates obtained by using anti-El, anti-E2, and anti-I-AP
monoclonal antibodies, respectively. MHV mRNAs 1 through 7 are
indicated on the left.
FIG. 1. Immunoprecipitation of RNA from pelleted MHV vi-
rions. Lanes: A, genomic-length RNA extracted from the pelleted
virions with some contamination from mRNAs 5, 6, and 7; B, no
RNA recovered in the absence of antibody; C, RNA of genomic
length immunoprecipitated by using anti-N monoclonal antibody; D
and E, no RNA recovered with anti-El or anti-E2 monoclonal
antibodies.
RESULTS
Association of N protein with viral RNA. Monoclonal
antibodies specific for the N protein, the El envelope
glycoprotein, and the E2 envelope glycoproteins of the A59
strain of MHV (16) were tested to determine whether a
specific interaction between a particular viral structural
protein and the MHV genomic RNA could be demonstrated
by coimmunoprecipitation. Antibodies were incubated with
concentrated 32P-labeled detergent-disrupted A59 virions.
The RNA was extracted from the immunoprecipitated com-
plexes and analyzed by electrophoresis on denaturing aga-
rose gels. Anti-N monoclonal antibody immunoprecipitated
MHV genomic RNA as part of an N protein-RNP complex
(Fig. 1). No RNA was detected in immunoprecipitates
formed by using the anti-El, anti-E2, or irrelevant anti-major
histocompatibility complex class II I-AP monoclonal anti-
bodies. These data support previous studies indicating that
N protein interacts with the genomic RNA to form a helical
nucleocapsid structure (38) and demonstrate the feasibility
of examining RNA-protein interactions by immunoprecipi-
tation.
We next analyzed the RNA species immunoprecipitated
with anti-N monoclonal antibody from lysates of 32P-labeled
actinomycin D-treated MHV-infected cells. Anti-N mono-
clonal antibody immunoprecipitated not only genomic RNA
(RNA 1) but, surprisingly, the other six virus-specific intra-
cellular RNAs as well (Fig. 2). Also, no virus-specific
mRNAs were immunoprecipitated with monoclonal antibod-
ies specific for either the El or E2 protein (Fig. 2). Immu-
noprecipitation of individual El or E2 mRNA from poly-
somes was not detected because of the dissociation of the
complexes with EDTA before immunoprecipitation (see
Materials and Methods). In addition, no virus-specific RNA
was immunoprecipitated with the antibody specific for the
I-AP protein. These data suggest that all seven viral intracel-
lular mRNAs exist as RNP complexes during infection.
The specificity of the immunoprecipitation of the intracel-
lular virus-specific mRNAs by anti-N monoclonal antibody
was further examined in experiments designed to clearly
demonstrate specificity for MHV RNAs. First, cells were
coinfected with VSV and MHV in the presence of actino-
mycin D to determine whether the MHV N protein was
associated with VSV RNA during coinfection as previously
suggested (29). These experiments are critical, since VSV
RNAs probably would be immunoprecipitated if nonspecific
interactions occur during sample preparation. Coinfected
cells contained both MHV and VSV RNA (Fig. 3). The
relative amounts of VSV and MHV RNA in the coinfected
cells varied slightly from experiment to experiment. Figure 3
shows the results of an experiment in which relatively equal
amounts were present. More importantly, the MHV-specific
anti-N monoclonal antibodies immunoprecipitated only
MHV-specific mRNAs but not VSV RNA from the coinfec-
ted cells.
Cells were also prelabeled overnight with [3H]uridine to
label host cell RNAs. Label was removed, the cells were
infected and treated with actinomycin D, and the intracellu-
lar RNAs were immunoprecipitated as described above.
Control cells were infected, treated with actinomycin D, and
radiolabeled with [3H]uridine during infection. Cells labeled
during infection yielded only virus-specific mRNAs after
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FIG. 3. Immunoprecipitation of MHV-specific RNA from cells
coinfected with VSV. Lanes: A, pattern of RNA extracted from
MHV-infected cells; B, RNA extracted from VSV-infected cells; C,
RNA extracted from cells coinfected with both VSV and MHV.
Note that most MHV mRNAs (numbered 1 through 7 on the left) can
be detected. Lane D, RNA immunoprecipitated from cells coinfec-
ted with VSV and MHV, demonstrating that only MHV mRNA is
recovered by using the anti-N monoclonal antibody.
immunoprecipitation with anti-N monoclonal antibody.
RNA immunoprecipitated from cells labeled before infection
contained no host cell RNA species; however, a very small
quantity of virus-specific mRNA, presumably derived from
the turnover of [3H]uridine during the infection, was de-
tected (data not shown). Finally, RNA from infected and
uninfected cells was immunoprecipitated with anti-N mono-
clonal antibody and examined for actin mRNA by Northern
blot analysis. Similar amounts of actin mRNA were detected
in infected and uninfected control cells; however, no actin
RNA was detected in the immunoprecipitates from either
infected or uninfected cells (data not shown). These data
indicate that the MHV N protein is not associated with either
host cell or VSV mRNA molecules and suggest that a
specific interaction between the MHV N protein and viral
RNA occurs during infection.
Mapping the N binding site to a location within the leader
RNA. Immunoprecipitation of all the MHV genomic and
subgenomic mRNAs suggested that the N binding site must
reside within sequences common to each RNA. The 5' and 3'
ends of all seven MHV RNAs are conserved because of the
presence of a common leader RNA at the 5' end and the
nested-set structure at-the 3' end (21, 22). Previous results
from our laboratories have also demonstrated that several
small leader-containing RNAs of 65 to 84 nucleotides in
length are derived from the 5' end of the viral genome and
may function as primers in mRNA synthesis (4, 6). To
FIG. 4. Immunoprecipitation of MHV small leader-containing
RNAs. Cultures of infected cells were lysed and immunoprecipi-
tated with a variety of antisera directed against MHV structural
proteins or antiserum obtained from lupus patients. The RNA
protein complexes were extracted, and the nucleic acid was sepa-
rated on 8% polyacrylamide gels. After electrotransfer to Zeta-
Probe paper, the blots were hybridized with a leader-specific cDNA.
Lanes: 1, RNA immunoprecipitated with anti-N; 2, immunoprecip-
itation with anti-E2; 3, total RNA extracted from MHV-infected
cells. Nucleotide numbers are shown on the right.
determine whether the small leader RNAs of MHV bind N,
we performed immunoprecipitations using monoclonal anti-
bodies specific for the MHV N and E2 proteins and a number
of serum samples from systemic lupus erythematosis pa-
tients containing antibodies specific for the La, Sm, RNP,
and Rho proteins. These serum samples were tested because
previous data have demonstrated that the VSV leader RNA
is bound to the host La protein (20). Immunoprecipitated
RNA from infected cells was separated on 8% polyacryl-
amide gels, transferred to Zeta-Probe paper and hybridized
with a nick-translated leader-specific cDNA probe (E1-L).
Anti-N monoclonal antibody immunoprecipitated the small
MHV leader RNAs of 65 nucleotides or longer, but not the
47- or 50-nucleotide RNAs. It is unclear whether the 57-
nucleotide leader RNA is precipitated by N (Fig; 4). A slight
size difference (2 to 5 nucleotides) was detected in the 74-,
77-, and 84-nucleotide RNAs between the immunoprecipi-
tated and nonprecipitated RNA. Although the exact reason
for this is unclear, it was probably caused by endogenous or
exonuclease activities, or both, present during immunopre-
cipitation. Antibodies with specificities for the MHV El,
VOL. 62, 1988
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Rho, Sm, RNP, and La proteins did not immunoprecipitate
the small leader RNAs of MHV (data not shown).
In addition to the small leader-containing RNAs, leader-
containing RNAs of 100 nucleotides and larger were also
detected (Fig. 4). We have previously demonstrated that
specific, highly reproducible subsets of these small RNAs
originate during the transcription (4). Furthermore, se-
quence analysis suggests that these RNAs are synthesized
by transcriptional pausing in AU-rich regions or regions of
secondary structure (4). To determine whether the N protein
is also bound to these larger leader-containing RNAs, we
separated immunoprecipitated RNA from MHV-infected
cells under conditions which resolved RNAs 100 to 300
nucleotides long (4). These RNAs were hybridized with a
radiolabeled cDNA specific for nucleotides 90 to 609 in the
mRNA 6 (gene F) sequence. Transcripts of identical length
were present in the anti-N precipitated and control RNA
preparations (Fig. 5). These RNAs are identical in size to
those previously reported on the replicative-intermediate
(RI) RNA during mRNA 6 transcription (4). Similar results
were also obtained with a gene A-specific cDNA probe (data
not shown). No RNA was detected after immunoprecipita-
tion with the anti-E2 monoclonal antibody. Since the only 5'
sequences common to mRNA 6 and mRNA 1 are within the
leader RNA, these data suggest that the N protein binds to
sequences contained within or adjacent to the leader RNA
sequences.
Subcellular locations of N-bound leader-containing RNAs.
MHV leader RNA synthesis is discontinuous from mRNA
synthesis, and the leader RNA(s) probably act in trans to
prime viral transcription (4-6, 25, 32). The data described
above suggest that the small leader RNAs are bound to N in
an RNP complex. However, it is not clear whether a
leader-containing RNP complex or a naked RNA molecule is
released from the template to act in trans as a primer for
subgenomic mRNA synthesis. Previous data have demon-
strated that MHV leader RNAs are associated with the
cellular membranes and cytoplasmic fractions in roughly
equal molar ratios (6). To determine whether N is associated
with the free leader RNAs, the subcellular location of the
leader-RNP complexes was determined by separating the
membrane (P100) and cytosolic (S100) fractions by ultracen-
trifugation as previously described (6). Subcellular fractions
were immunoprecipitated with anti-N or anti-I-A monoclo-
nal antibodies, and the small RNAs were separated by
polyacrylamide gel electrophoresis. After transfer to Zeta-
Probe paper, the blots were hybridized with a nick-trans-
lated leader-specific cDNA (E1-L) probe. Identically sized
leader RNAs were present in immunoprecipitates and con-
trol preparations (Fig. 6), indicating that the small leader
RNAs of MHV are associated with the N protein in both the
membrane and cytosolic fractions. These data are consistent
with previous data indicating that MHV leader-containing
RNAs and the N protein are associated with the membranes
of infected cells (6, 36).
Analysis of N-function in viral transcription. Anti-N mono-
clonal antibody inhibits the in vitro transcription of viral
RNA, suggesting that the N protein is tightly associated with
the transcription complex (12). To further clarify the role of
N in viral transcription, we examined the interaction of N
with the RI RNA. RI RNA consists of a genome-length
negative-stranded RNA hydrogen bonded to nascent plus-
strands representing newly transcribed RNA (5). Since little,
if any, free negative-stranded RNA is present in infected
cells (31), the presence of negative-stranded RNA in the
immunoprecipitates would suggest that N was bound to the
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FIG. 5. N binding by leader RNAs originating during mRNA 6
transcription. Cultures of cells were lysed and immunoprecipitated
with anti-N or anti-E2 monoclonal antibodies as described in Mate-
rials and Methods. The complexes were extracted and separated on
8% polyacrylamide gels under conditions which resolve small RNAs
100 to 300 nucleotides long. The RNA was electroblotted to Zeta-
Probe paper and hybridized with a nick-translated cDNA clone
spanning nucleotides 90 to 609 in the gene F sequence (6). Lanes: 1,
anti-E2-immunoprecipitated RNAs from infected cells; 2, anti-N-
immunoprecipitated RNAs from infected cells; 3, total infected-cell
intracellular RNA; 4, total RNA from uninfected cells. Nucleotide
numbers are shown on the right.
RNA of the RI complex. Therefore, lysates of infected and
uninfected cells were incubated with either anti-N or anti-E2
monoclonal antibodies, immunoprecipitated, and probed for
the presence of negative-stranded RNA. Studies in our
laboratory and others indicate that strand-specific RNA
probes are capable of detecting as little as i~t 0
infectious units of virus and that in vitro-transcribed plus-
sense RNAs do not bind to purified genomic RNA (41). The
J. VIROL.
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FIG. 6. Subcellular location of leader RNA-N protein RNPs.
Cultures of infected cells were lysed and separated into S100 and
P100 fractions (5). The fractions were immunoprecipitated with
anti-N or anti-I-AP monoclonal antibodies and separated on 12%
polyacrylamide gels containing urea. After electrotransfer, the fil-
ters were hybridized with a leader-specific cDNA probe (6), washed,
and exposed to XAR-5 film at -70°C. Lanes: 1, S100 anti-I-A; 2,
P100 anti-I-A; 3, P100 anti-N; 4, S100 anti-N; 5, infected-cell
control; 6, uninfected-cell control. Nucleotide numbers are shown
on the right.
RNA was probed for the presence of negative-stranded RNA
with in vitro-transcribed plus-sense viral RNAs. Negative-
stranded RNA was immunoprecipitated with anti-N but not
anti-E2 monoclonal antibody (Fig. 7), consistent with the
suggestion that the N protein is associated with the tran-
scription complex (12). These data cannot distinguish be-
tween N binding to negative-stranded RNA and the coim-
munoprecipitation of the negative-stranded RNA as a
component of the RI complex via N interactions with the
leader-containing nascent plus-strands on the RI RNA.
While it is possible that negative-stranded RNA associates
with plus-strand RNA during extraction and immunoprecip-
itation, Sawicki and Sawicki (31) have shown that little, if
any, free negative-stranded RNA is present in infected cells.
This suggests that the negative-stranded RNA is coimmuno-
precipitated as part of the RI complex.
The P100 and S100 subcellular fractions were also exam-
ined for the presence of N protein associated with negative-
stranded RNA. Virtually all of the N-bound negative-
stranded RNA (90%) was associated with membrane
fractions by densitometric scanning of slot blots (Fig. 8). The
small amount of negative-stranded RNA detected in the
cytosol probably represents contaminating membrane
FIG. 7. Analysis of N-protein negative-stranded RNA interac-
tion. Intracellular RNA was extracted from MHV-infected cells and
coimmunoprecipitated with monoclonal antibodies directed against
the MHV N or E2 structural proteins. The RNA was denatured,
bound to nitrocellulose filters, and hybridized with radiolabeled
plus-stranded RNA transcribed in vitro with the T7 RNA polymer-
ase. Lanes 1 through 3, 10-fold dilutions of intracellular RNA.
UNI-DBT, Uninfected DBT cells.
present during separation. These data support previous
findings suggesting that free leader RNA-N complexes were
present in the cytosol and were dissociated from the nega-
tive-stranded template. These data further support the con-
tention that the N protein is associated with the membrane-
bound transcription complex (9, 10).
DISCUSSION
In this report, we have demonstrated a specific interaction
between the MHV N protein and MHV viral mRNAs.
Neither prelabeled host cell RNA, actin mRNA, nor VSV
RNAs are associated with the MHV N protein. Previous
studies in our laboratory have suggested that the leader RNA
of MHV acts in trans as a primer for subgenomic mRNA
synthesis, on the basis both of findings that leader RNA
reassortment occurs at high frequency during MHV infec-
tion and of the presence of small leader RNAs in infected-
cell extracts (4-6, 25, 32). Although the exact leader RNA
which functions in virus transcription has not been identi-
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FIG. 8. Immunoprecipitation of MHV negative-stranded RNA
from membrane and cytosolic fractions. Intracellular RNA was
extracted from MHV-infected cells, separated into P100 and S100
fractions by ultracentrifugation, and precipitated with anti-N mono-
clonal antibody. The RNA was extracted, bound to nitrocellulose
filters, and hybridized with plus-sense radiolabeled MHV RNAs
transcribed in vitro with the T7 polymerase. Horizontal lanes: 1,
anti-N-precipitated P100; 2, anti-N-precipitated S100; 3, intracellu-
lar RNA from MHV-infected cells; 4, purified MHV genomic RNA;
5, uninfected cells. Vertical lanes A through C, 10-fold dilutions of
intracellular RNA.
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fied, several small leader RNAs 65 to 84 nucleotides long
which could serve a primer function have been identified (4,
5). The data presented in this article indicate that an N
binding site is present within the MHV leader RNA se-
quence and suggest that this interaction may be important in
viral transcription.
The N proteins of a variety of helical negative-stranded
RNA viruses are essential for virus transcription. For exam-
ple, the N protein of VSV is believed to regulate the shift
from transcription to replication (2, 3). At least two distinct
forms of the VSV N protein have been identified by mono-
clonal antibodies in cytoplasmic pools of infected cells (2).
These studies imply that the availability of the unbound VSV
N protein controls the rate of genomic RNA replication. The
N proteins of VSV and La Crosse virus are also bound to the
viral RNAs in an RNA complex (17, 28, 30); however, the
function of these complexes in virus replication is unclear.
Coronaviruses represent the only plus-polarity RNA animal
viruses with helical nucleocapsids (38). Compton et al. (12)
have clearly shown that the N protein of MHV functions in
viral RNA synthesis, since anti-N monoclonal antibody
inhibits in vitro transcription. Similar results have been
demonstrated in our laboratory (P. R. Brayton et al., unpub-
lished observation). However, the nature of the interaction
between N and the transcriptional complex is unclear. Our
findings suggest that N is bound to the cytosol- and mem-
brane-bound small leader RNAs 65 to 84 nucleotides long as
well as to the transcription complex. Although the exact
leader RNA which functions in viral transcription has not
been identified, it is clear that trans-acting leader RNAs
function during MHV subgenomic RNA synthesis and that
the minimum size of this RNA is approximately 65 nucleo-
tides (25, 32). The data presented in this paper suggest that
such an RNA will contain a functional N binding site,
suggesting that a trans-acting leader RNA-N complex may
function during subgenomic mRNA synthesis. Immunopre-
cipitation of the negative-stranded RNA, as well as the small
leader RNAs originating during mRNA 6 transcription, also
suggests that N is associated with the transcription complex.
Since the nascent plus-strands on the RI RNA contain leader
RNA (4, 5), it seems likely that N protein binding is mediated
at least in part via these sequences. These data suggest that
N may play an important structural role in the transcription
complex; however, our data cannot exclude the possibility
that the N protein is complexed with negative-stranded RNA
or with other viral proteins which are directly bound to the
leader RNA.
VSV leader RNA is associated with the La protein but not
the Rho, RNP, or SM proteins (20). We were able to
immunoprecipitate the MHV leader RNA or mRNA species
with any of the serum samples from SLE patients containing
antibodies to the La, Rho, RNP, or Sm cellular proteins.
This is not surprising, since the physiological roles of the
VSV and MHV leader RNAs are quite different. In the case
of VSV, the leader RNA is transported to the nucleus, where
it inhibits host transcription, presumably by binding to
cellular La protein (3, 20). Conversely, MHV probably
inhibits the host cell macromolecular synthesis at the level of
translation (19), while leader RNA probably functions as a
primer for transcription of the subgenomic mRNAs (4-6, 24).
The VSV leader RNA is also bound to the nucleocapsid
protein in an RNP complex (3, 7). Since the leader RNA
sequences of VSV are also present in genomic RNA, but not
mRNA, it is thought that these sequences regulate encapsi-
dation of genome into RNP structures. Interestingly, the
VSV mRNAs are also detected in RNP complexes but are
not packaged (17). In the case of the MHV leader RNA,
these sequences are present on all viral mRNAs, suggesting
that other factors are involved in regulating the encapsida-
tion of the genomic RNA, but not mRNA, into infectious
virions. Encapsidation of viral genomic RNAs is a complex
process frequently requiring one or more binding sites (26).
The exact role of the leader sequence in encapsidation of the
MHV genome is currently under study.
Presently, the exact nucleotides within the leader RNA
sequence which bind N have not been determined; however,
the data presented here suggest that the site may reside 3' of
nucleotide 57, since we were unable to demonstrate that the
small leader RNAs of 47, 50, and 57 nucleotides were
present in infected cells as RNP complexes. Alternatively, N
may require a minimum RNA length for high-affinity bind-
ing. In the accompanying article we demonstrate that MHV
leader RNA sequences, transcribed in vitro by the T7 RNA
polymerase, bind to N in a specific and high-affinity fashion,
while internal MHV sequences in gene A (genome RNA) and
gene F (mRNA 6) do not bind to N (35). Together with the
immunoprecipitation data presented in this study, these data
suggest that the leader RNA contains a sequence-specific N
binding site. More importantly, the accompanying article
describes a novel approach for determining the N binding
site within the leader RNA sequences as well as other
regions in the viral genome (35).
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